1. Home
  2. ADMA vs BHC Comparison

ADMA vs BHC Comparison

Compare ADMA & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$9.15

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

HOLD

Current Price

$4.78

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
BHC
Founded
2004
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
ADMA
BHC
Price
$9.15
$4.78
Analyst Decision
Strong Buy
Hold
Analyst Count
4
3
Target Price
$25.67
$8.00
AVG Volume (30 Days)
3.6M
3.0M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
423.08
EPS
0.19
N/A
Revenue
$42,219,783.00
$8,724,000,000.00
Revenue This Year
$27.46
$4.61
Revenue Next Year
$22.11
N/A
P/E Ratio
$48.79
N/A
Revenue Growth
43.85
N/A
52 Week Low
$7.21
$4.57
52 Week High
$20.46
$8.69

Technical Indicators

Market Signals
Indicator
ADMA
BHC
Relative Strength Index (RSI) 59.64 42.89
Support Level $7.38 $4.57
Resistance Level $11.42 $6.31
Average True Range (ATR) 0.32 0.27
MACD 0.10 0.01
Stochastic Oscillator 84.09 12.36

Price Performance

Historical Comparison
ADMA
BHC

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Share on Social Networks: